MANGROVE PARTNERS IM, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001535392

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHigh Turnover how tags are computed

Q4 2023 · 173 positions · Total reported value $1.46B · Top-10 concentration 31.4% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 69.6% · 143 new · 48 cut · 205 exited

Active Share (vs S&P 500): 99.2% · vs QQQ: 99.6% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -8.2% · vs SPY -10.3% · Prev Value $1.52B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +4.0% · vs SPY +1.8% · Latest Value $1.47B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2023 13F filing, MANGROVE PARTNERS IM, LLC disclosed 173 equity positions with a combined reported value of $1.46B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 31.4% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.

The largest disclosed positions as of Q4 2023 were IJR ($88.06M), MRTX ($64.73M), WFRD ($56.82M). By sector, the heaviest allocations are Consumer Discretionary 20.0%, Financials 11.9%. Versus the prior quarter, allocation shifted toward Other (+7.6pp), Energy (+2.0pp) and away from Real Estate (-0.8pp), Health Care (-1.0pp).

Versus the prior quarter, MANGROVE PARTNERS IM, LLC opened 143 new positions, trimmed 48 and fully exited 205, a turnover rate of 69.6% of positions. The portfolio's overlap with the prior quarter was 61% of names.

The largest new positions opened in Q4 2023 were IJR ($88.06M), MRTX ($64.73M), SPLK ($32.00M).

Of the 205 positions fully exited versus the prior quarter, the largest were TXNM ($30.50M), BABA ($27.42M), CNH ($21.23M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2023)

  • IJR ISHARES TR · $88.06M
  • MRTX MIRATI THERAPEUTICS INC · $64.73M
  • SPLK SPLUNK INC · $32.00M
  • TSEM TOWER SEMICONDUCTOR LTD · $24.81M
  • NGMS NEOGAMES S A · $16.46M
  • X UNITED STATES STL CORP NEW · $16.17M
  • AMED AMEDISYS INC · $16.13M
  • SOVO SOVOS BRANDS INC · $15.86M

Fully Exited (vs previous quarter)

  • TXNM TXNM ENERGY INC · prev qtr: $30.50M
  • BABA ALIBABA GROUP HLDG LTD · prev qtr: $27.42M
  • CNH CNH INDL N V · prev qtr: $21.23M
  • BBWI BATH & BODY WORKS INC · prev qtr: $18.82M
  • SGEN SEAGEN INC · prev qtr: $14.92M
  • SCPL SCIPLAY CORPORATION · prev qtr: $14.22M
  • BHC BAUSCH HEALTH COS INC · prev qtr: $13.97M
  • EFHTW EF HUTTON ACQUISITION CORP I · prev qtr: $10.49M

Insider Transactions (Form 4)

Latest MANGROVE PARTNERS IM, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Mangrove Partners IM is an SEC-registered 13F filer based in Greenwich, CT, United States. As of Q2 2026 it reported 426 US equity positions with a combined value of $1.52B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: GREENWICH, CT, United States
  • SEC registration: 801-78070 (status: Approved), registered 2013-05-20
  • Regulatory AUM (Form ADV): $2.71B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: mangrovepartners.com

Portfolio Structure

  • 426 positions · $1.52B reported value (Q2 2026)
  • Top 10 holdings = 38.1% of reported value
  • Largest position: INDV (INDIVIOR PHARMACEUTICALS INC) at 7.2%
  • Average position size: $3.57M

Sector Tilt

  • Consumer Discretionary 20.8%
  • Financials 18.5%
  • Information Technology 13.9%
  • (classified holdings cover 89% of value)

Quarterly Activity

  • Q2 2026: 198 new, 40 added, 61 reduced, 199 exited
  • 127 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Financials 11.9%
Technology 7.6%
Energy 2.0%
Other 49.2%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 813.52K $88.06M 6.02%
6.02%
New
2 1.10M $64.73M 4.42%
4.42%
New
3 580.78K $56.82M 3.88%
3.88%
Reduce
4 550.01K $40.88M 2.79%
2.79%
Hold
5 2.69M $39.90M 2.73%
2.73%
Hold
6 489.73K $37.46M 2.56%
2.56%
Hold
7 691.87K $35.42M 2.42%
2.42%
Hold
8 638.77K $32.56M 2.23%
2.23%
Hold
9 210.02K $32.00M 2.19%
2.19%
New
10 1.15M $31.50M 2.15%
2.15%
Hold
11 565.01K $31.28M 2.14%
2.14%
Hold
12 359.68K $31.16M 2.13%
2.13%
Hold
13 419.90K $28.79M 1.97%
1.97%
Hold
14 203.24K $28.39M 1.94%
1.94%
Hold
15 2.05M $28.09M 1.92%
1.92%
Hold
16 1.18M $27.04M 1.85%
1.85%
Hold
17 1.12M $26.36M 1.80%
1.80%
Add
18 813.04K $24.81M 1.70%
1.70%
New
19 1.29M $23.88M 1.63%
1.63%
Hold
20 586.53K $21.93M 1.50%
1.50%
Add
21 659.55K $20.38M 1.39%
1.39%
Hold
22 8.75M $20.22M 1.38%
1.38%
Add
23 326.75K $19.97M 1.36%
1.36%
Hold
24 7.95M $18.45M 1.26%
1.26%
Hold
25 338.64K $17.74M 1.21%
1.21%
Add
26 1.01M $16.55M 1.13%
1.13%
Hold
27 574.87K $16.46M 1.12%
1.12%
New
28 332.46K $16.17M 1.10%
1.10%
New
29 169.63K $16.13M 1.10%
1.10%
New
30 720.05K $15.86M 1.08%
1.08%
New
31 201.08K $15.31M 1.05%
1.05%
Reduce
32 1.28M $13.91M 0.95%
0.95%
Hold
33 635.59K $12.40M 0.85%
0.85%
Reduce
34 228.12K $11.46M 0.78%
0.78%
Add
35 173.87K $10.78M 0.74%
0.74%
Hold
36 951.09K $10.40M 0.71%
0.71%
Hold
37 1.87M $10.32M 0.70%
0.70%
New
38 950.00K $10.30M 0.70%
0.70%
Hold
39 950.00K $10.30M 0.70%
0.70%
Hold
40 953.15K $10.23M 0.70%
0.70%
Hold
41 949.91K $10.22M 0.70%
0.70%
Hold
42 950.10K $10.19M 0.70%
0.70%
Hold
43 900.00K $10.19M 0.70%
0.70%
Hold
44 598.73K $10.12M 0.69%
0.69%
New
45 439.31K $10.07M 0.69%
0.69%
Hold
46 921.90K $10.06M 0.69%
0.69%
Reduce
47 930.09K $10.02M 0.68%
0.68%
Hold
48 906.10K $9.86M 0.67%
0.67%
Hold
49 900.00K $9.78M 0.67%
0.67%
Hold
50 896.70K $9.51M 0.65%
0.65%
Hold

FAQ

What did MANGROVE PARTNERS IM, LLC buy in 2023-Q4?

In its 2023-Q4 13F filing, MANGROVE PARTNERS IM, LLC reported 173 equity positions worth $1.46B in aggregate; its largest disclosed positions were IJR ($88.06M), MRTX ($64.73M), WFRD ($56.82M).

How large is MANGROVE PARTNERS IM, LLC's portfolio?

MANGROVE PARTNERS IM, LLC reported $1.46B of long equity holdings across 173 positions as of 2023-Q4. Top-10 holdings account for 31.4% of reported value.

What is MANGROVE PARTNERS IM, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/mangrove-partners-im/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →